New study tracks psoriasis Drug's Real-World impact on diverse skin types
Knowledge-focused
Recruiting now
This study follows 80 adults in Canada with moderate-to-severe psoriasis who are starting the drug tildrakizumab. Researchers want to see how the treatment affects quality of life and skin clearing over one year, especially in people with darker skin tones (Fitzpatrick type III a…
Sponsor: Chronicle Academy • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC